Patents by Inventor Agnes B. Ciarletta

Agnes B. Ciarletta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic uses of IL-3
    Patent number: 5639453
    Abstract: A method of treating leukopenia, by administering an IL-3 polypeptide, is disclosed.
    Type: Grant
    Filed: January 10, 1995
    Date of Patent: June 17, 1997
    Assignee: Genetics Institute, Inc.
    Inventors: Steven C. Clark, Agnes B. Ciarletta, Yu-Chung Yang
  • DNA encoding the human cytokine, interleukin-9
    Patent number: 5580753
    Abstract: The invention involves DNA molecules which encode a human protein of 144 amino acids, referred to as interleukin-9, or IL-9. The protein is an erythropoietic growth factor. Also disclosed are processes for producing the IL-9 protein via genetic engineering techniques.
    Type: Grant
    Filed: April 27, 1990
    Date of Patent: December 3, 1996
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Yu-Chung Yang, Agnes B. Ciarletta, Susan T. Ricciardi, Steven C. Clark, Robert E. Donahue
  • Human cytokine IL-9
    Patent number: 5414071
    Abstract: Provided by the present invention is a novel cytokine, IL-9, an approximately 144 amino acid protein, characterized by an apparent molecular weight of between 20 to 30 kD and having biological activity in an MO7E cell assay. The cytokine can be used, inter alia, as a mitogen, as an antigen, and to regulate hematopoiesis.
    Type: Grant
    Filed: August 23, 1991
    Date of Patent: May 9, 1995
    Assignee: Genetics Institute, Inc.
    Inventors: Yu-Chung Yang, Agnes B. Ciarletta, Susan T. Ricciardi, Steven C. Clark
  • Method of inducing leukocytosis with a combination of IL-3 and GM-CSF
    Patent number: 5032395
    Abstract: An improved method for inducing leukocytosis in a primate is disclosed. The method includes co-administering IL-3 in conjunction with GM-CSF, such that the leukocyte count in the primate is synergistically raised.
    Type: Grant
    Filed: June 23, 1989
    Date of Patent: July 16, 1991
    Assignee: Genetics Institute, Inc.
    Inventors: Steven C. Clark, Agnes B. Ciarletta, Yu-Chung Yang, Robert E. Donahue
  • Primate hematopoietic growth factors IL-3 and pharmaceutical compositions
    Patent number: 4959455
    Abstract: A novel family of primate IL-3 polypeptides is provided via recombinant techniques.
    Type: Grant
    Filed: March 4, 1987
    Date of Patent: September 25, 1990
    Assignee: Genetics Institute, Inc.
    Inventors: Steven C. Clark, Agnes B. Ciarletta, Yu-Chung Yang
  • Recombinant DNA encoding novel family of primate hematopoietic growth factors
    Patent number: 4877729
    Abstract: A novel family of primate IL-3-like polypeptides is provided via recombinant techniques.
    Type: Grant
    Filed: October 7, 1986
    Date of Patent: October 31, 1989
    Assignee: Genetics Institute, Inc.
    Inventors: Steven C. Clark, Agnes B. Ciarletta, Yu-Chung Yang